Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The report details the trend, potential and market size of Oncolytic Virus Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncolytic Virus Therapymarket, defines the market attractiveness level of Oncolytic Virus Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncolytic Virus Therapy industry, describes the types of Oncolytic Virus Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncolytic Virus Therapy market and the development prospects and opportunities of Oncolytic Virus Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncolytic Virus Therapy market in Chapter 13.
By Player:
Oncolys BioPharma
Cold Genesys
SillaJen Biotherapeutics
Sorrento Therapeutics
Viralytics
Genelux Corporation
Transgene SA
TILT Biotherapeutics
Vyriad
Amgen
Targovax
Lokon Pharma
PsiOxus Therapeutics
Oncolytics Biotech
By Type:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By End-User:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncolytic Virus Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncolytic Virus Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncolytic Virus Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncolytic Virus Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncolytic Virus Therapy Market Analysis and Outlook to 2022
-
7.1 Global Oncolytic Virus Therapy Consumption (2017-2022)
-
7.2 United States Oncolytic Virus Therapy Consumption (2017-2022)
-
7.3 Europe Oncolytic Virus Therapy Consumption (2017-2022)
-
7.4 China Oncolytic Virus Therapy Consumption (2017-2022)
-
7.5 Japan Oncolytic Virus Therapy Consumption (2017-2022)
-
7.6 India Oncolytic Virus Therapy Consumption (2017-2022)
-
7.7 South Korea Oncolytic Virus Therapy Consumption (2017-2022)
8 Region and Country-wise Oncolytic Virus Therapy Market Analysis and Outlook to 2028
-
8.1 Global Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.2 United States Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.4 China Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.6 India Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Oncolytic Virus Therapy Consumption Forecast (2022-2028)
9 Global Oncolytic Virus Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Oncolytic Virus Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncolytic Virus Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Oncolytic Virus Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Oncolytic Virus Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncolytic Virus Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncolytic Virus Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncolytic Virus Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncolytic Virus Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncolytic Virus Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncolytic Virus Therapy Market Competitive Analysis
-
14.1 Oncolys BioPharma
-
14.1.1 Oncolys BioPharma Company Details
-
14.1.2 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Service
-
14.2 Cold Genesys
-
14.2.1 Cold Genesys Company Details
-
14.2.2 Cold Genesys Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cold Genesys Oncolytic Virus Therapy Product and Service
-
14.3 SillaJen Biotherapeutics
-
14.3.1 SillaJen Biotherapeutics Company Details
-
14.3.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Service
-
14.4 Sorrento Therapeutics
-
14.4.1 Sorrento Therapeutics Company Details
-
14.4.2 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Service
-
14.5 Viralytics
-
14.5.1 Viralytics Company Details
-
14.5.2 Viralytics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Viralytics Oncolytic Virus Therapy Product and Service
-
14.6 Genelux Corporation
-
14.6.1 Genelux Corporation Company Details
-
14.6.2 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genelux Corporation Oncolytic Virus Therapy Product and Service
-
14.7 Transgene SA
-
14.7.1 Transgene SA Company Details
-
14.7.2 Transgene SA Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Transgene SA Oncolytic Virus Therapy Product and Service
-
14.8 TILT Biotherapeutics
-
14.8.1 TILT Biotherapeutics Company Details
-
14.8.2 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Service
-
14.9 Vyriad
-
14.9.1 Vyriad Company Details
-
14.9.2 Vyriad Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Vyriad Oncolytic Virus Therapy Product and Service
-
14.10 Amgen
-
14.10.1 Amgen Company Details
-
14.10.2 Amgen Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Amgen Oncolytic Virus Therapy Product and Service
-
14.11 Targovax
-
14.11.1 Targovax Company Details
-
14.11.2 Targovax Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Targovax Oncolytic Virus Therapy Product and Service
-
14.12 Lokon Pharma
-
14.12.1 Lokon Pharma Company Details
-
14.12.2 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Lokon Pharma Oncolytic Virus Therapy Product and Service
-
14.13 PsiOxus Therapeutics
-
14.13.1 PsiOxus Therapeutics Company Details
-
14.13.2 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Service
-
14.14 Oncolytics Biotech
-
14.14.1 Oncolytics Biotech Company Details
-
14.14.2 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncolytic Virus Therapy
-
Figure Oncolytic Virus Therapy Picture
-
Table Global Oncolytic Virus Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncolytic Virus Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncolytic Virus Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure United States Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncolytic Virus Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncolytic Virus Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Oncolys BioPharma (Foundation Year, Company Profile and etc.)
-
Table Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolys BioPharma Oncolytic Virus Therapy Product and Service
-
Table Cold Genesys (Foundation Year, Company Profile and etc.)
-
Table Cold Genesys Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cold Genesys Oncolytic Virus Therapy Product and Service
-
Table SillaJen Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Service
-
Table Sorrento Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Product and Service
-
Table Viralytics (Foundation Year, Company Profile and etc.)
-
Table Viralytics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viralytics Oncolytic Virus Therapy Product and Service
-
Table Genelux Corporation (Foundation Year, Company Profile and etc.)
-
Table Genelux Corporation Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genelux Corporation Oncolytic Virus Therapy Product and Service
-
Table Transgene SA (Foundation Year, Company Profile and etc.)
-
Table Transgene SA Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transgene SA Oncolytic Virus Therapy Product and Service
-
Table TILT Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Product and Service
-
Table Vyriad (Foundation Year, Company Profile and etc.)
-
Table Vyriad Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vyriad Oncolytic Virus Therapy Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Oncolytic Virus Therapy Product and Service
-
Table Targovax (Foundation Year, Company Profile and etc.)
-
Table Targovax Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targovax Oncolytic Virus Therapy Product and Service
-
Table Lokon Pharma (Foundation Year, Company Profile and etc.)
-
Table Lokon Pharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lokon Pharma Oncolytic Virus Therapy Product and Service
-
Table PsiOxus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Product and Service
-
Table Oncolytics Biotech (Foundation Year, Company Profile and etc.)
-
Table Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Oncolytic Virus Therapy Product and Service
-
